Moneyview IPO: 98.46x demand, GMP hints ₹47-48

Moneyview IPO snapshot driving the buzz

Moneyview IPO became a high-volume discussion topic after it closed with a headline subscription figure of 98.46 times. Social feeds repeatedly cited strong interest from QIBs and NIIs as the key driver. The issue size was reported as ₹1,091.68 crore across multiple posts and trackers. The price band was ₹32 to ₹34 per share, with the final issue price referenced at ₹34. The IPO was positioned as a book-built issue slated to list on both BSE and NSE. The tentative listing date mentioned consistently was October 1, 2026. A parallel thread of conversation focused on the grey-market premium and the implied listing price. The overall tone online was analytical rather than celebratory, with people comparing subscription data and GMP updates.

Subscription: 98.46x is the number most shared

The most-circulated end-of-bidding figure was 98.46 times subscription, cited as of 5:00 pm on September 28 as per NSE data. Several posts also quoted very large bid volumes, but the raw numbers varied by source. One widely-shared line said the issue received bids for 2,290 crore shares against 23.25 crore shares on offer. Another update said bids were 331 crore shares against the same 23.25 crore shares on offer, using exchange data at 11:48 am on September 28. Yet another data point referenced bids for 22.89 billion shares against 23.25 crore shares. Despite the variation in reported bid totals, the conversation converged on the final oversubscription headline. The mismatch in intermediate bid figures became a mini-topic on its own, with users asking which snapshot was being used. In practical terms, most retail discussions used the 98.46x figure as the base case for expectations going into listing.

Who drove demand: QIBs and NIIs in the spotlight

Posts repeatedly said the subscription was led by strong demand from QIBs and NIIs. Several mid-day updates during the final session also highlighted NIIs as a key contributor to the running total. This institutional-led narrative mattered because it shaped expectations about listing-day stability and depth of demand. Some social commentary framed it as a “quality bid book” because QIB interest was mentioned prominently, though no detailed category-wise subscription figures were provided in the shared context. Allocation split data did circulate in one post: 20% to QIB, 15% to NII, 35% to RII, and 30% to Others. That split was used by users to discuss how much stock might be available in each bucket. People also used it to estimate how tight retail allotment could be at high oversubscription. The dominant takeaway across threads was that the demand profile looked institution-heavy. However, most discussions stopped short of making claims beyond what subscription and allocation snapshots indicate.

Issue size and structure: fresh issue plus OFS

Moneyview IPO was consistently described as a ₹1,091.68 crore issue with two components. The fresh issue was stated as 22.06 crore shares aggregating to ₹750 crore. The offer for sale was cited as 10.05 crore shares worth ₹341.68 crore, with one place showing 10.04 crore shares. Multiple trackers also summarised the total issue size as 32,10,82,435 shares. The face value was stated as ₹1 per share. Because this was a mix of fresh issue and OFS, social discussions separated “money to the company” from “shares sold by existing holders.” Most posts did not add further use-of-proceeds detail beyond the fresh issue number. People mainly used the structure to compare Moneyview with other mainboard offerings of similar size. The repeated numbers across different posts helped the structure narrative stay consistent even when bid counts differed.

Price band, lot size, and minimum application details

The price band was repeatedly quoted at ₹32 to ₹34 per share, with the cap price and final issue price both referenced at ₹34. Most social posts and IPO trackers said the retail lot size was 441 shares. Using the upper band, many calculated the minimum retail application as ₹14,994. A separate post cited a minimum investment of ₹14,112, which aligns with calculations at a lower price point. Another circulating table listed a “Bid Lot” of 176 equity shares, which created confusion in comments. Because 441 shares was the most repeated lot size figure, most discussions anchored to that for retail calculations. Some posts also said retail investors could apply up to 13 lots, equating to 5,733 shares or ₹1,94,922 at the cap price. The practical implication in discussions was that the ticket size was manageable for many retail applicants. Users also highlighted that applications needed to be in multiples of the lot size.

Grey market premium: what ₹13-₹14 implies

GMP updates were one of the most refreshed items in the Moneyview IPO chatter. One snapshot put GMP at 37.5%, implying an estimated listing price of ₹46.75. Another widely-cited update said GMP stood at ₹13, which implied an estimated listing price of about ₹47 against the ₹34 upper price band. A later pre-listing note referenced GMP at ₹14 per share as of October 1, 8:00 AM IST, implying around ₹48. These implied prices were repeatedly treated as indicative rather than certain. Many posts explicitly used the simple formula of issue price plus GMP to arrive at the estimate. The spread between ₹47 and ₹48 became a common range cited for “expected listing,” with some rounding differences. A separate line in the context also showed an “Estimated Listing Price” of ₹48.5, which sat in the same band. The overall GMP thread stayed focused on arithmetic rather than story-driven speculation.

Key dates investors tracked into listing day

The IPO opening date was consistently stated as September 24, 2026, and the closing date as September 28, 2026. The allotment finalisation date was cited as September 29, 2026. One schedule snippet also listed “Credit of Shares” on September 30, 2026. Listing was repeatedly stated as October 1, 2026, on both BSE and NSE. Some discussions focused on the gap between allotment and listing as a standard timeline check. Others used the timeline to plan when funds would be unblocked in case of non-allotment, though no specific unblocking date was provided. The timeline also framed how GMP was interpreted, with users noting that GMP can change quickly closer to listing. Conversations did not include any confirmed listing price from the exchange, only tentative estimates from GMP. The listing-day focus was therefore on whether the debut would align with the ₹47-₹48 implied band.

A quick table of the most-shared figures

The figures below compile the numbers that appeared repeatedly in Reddit and social posts, without reconciling conflicting bid-volume snapshots.

What to watch on October 1 based on social signals

Based on the context, the market’s first reference point is whether Moneyview lists near the GMP-implied ₹47-₹48 range. The second reference point is trading volume, because the IPO was discussed in the context of very large bid participation. If the debut is near the implied range, the conversation may shift to whether that premium holds beyond the first hour. If the debut is meaningfully below the implied range, the focus will likely be on how quickly GMP changed near listing. Since the subscription narrative highlighted QIB and NII participation, social chatter may also look for signs of institutional selling or holding, even if that cannot be confirmed from posts alone. Another watch item is whether the final exchange prints match the tentative dates and schedule cited. Retail participants will also compare their effective cost with where the stock trades post-listing. Importantly, the provided context does not include any confirmed listing price, only estimates derived from GMP. That keeps the discussion framed around probability rather than certainty.

Bottom line from the current discourse

Moneyview IPO is being discussed as a heavily subscribed mainboard issue with a clear final subscription headline of 98.46x. The structure and pricing are widely repeated and fairly consistent: ₹1,091.68 crore, ₹32-₹34 band, and issue price referenced at ₹34. The biggest divergence in social posts is in the raw bid-count snapshots, which vary across updates and timings. GMP, however, clustered into a narrow band of ₹13-₹14 near listing, translating into an implied price around ₹47-₹48. For many retail investors, the key practical numbers were the 441-share lot size and the ₹14,994 minimum at the cap price. The calendar also remained consistent, with allotment on September 29 and listing on October 1. Until the stock actually opens on the exchange, GMP remains the primary proxy being used in public discussions. Investors following the topic are therefore watching whether the debut validates that implied premium. The only firm conclusions supported by the shared context are subscription strength, the offer structure, and the publicly-circulated GMP-based estimates.